We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
-3.55%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$28.5B
AUM Growth
-$1.64B
Cap. Flow
-$541M
Cap. Flow %
-1.9%
Top 10 Hldgs %
23.41%
Holding
1,182
New
104
Increased
354
Reduced
497
Closed
123

Top Buys

Rank Stock Value
1
AMAT icon
Applied Materials
AMAT
+$94.3M
2
MSFT icon
Microsoft
MSFT
+$65.5M
3
LLY icon
Eli Lilly
LLY
+$58.4M
4
NVDA icon
NVIDIA
NVDA
+$58M
5
ABBV icon
AbbVie
ABBV
+$43.8M

Top Sells

Rank Stock Value
1
SLAB icon
Silicon Laboratories
SLAB
+$84.9M
2
ATVI
Activision Blizzard
ATVI
+$78.4M
3
BAC icon
Bank of America
BAC
+$64.2M
4
MA icon
Mastercard
MA
+$60.4M
5
MMM icon
3M
MMM
+$55.1M

Sector Composition

Rank Sector Weight
1 Technology 33.32%
2 Healthcare 19.18%
3 Consumer Discretionary 12.28%
4 Financials 8.16%
5 Industrials 7.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMAT icon
26
Applied Materials
AMAT
$347B
$183M 0.64%
1,319,940
+657,776
+99% +$94.3M
CSCO icon
27
Cisco
CSCO
$443B
$183M 0.64%
3,399,226
+121,468
+4% +$6.55M
EQIX icon
28
Equinix
EQIX
$99.4B
$182M 0.64%
251,054
+26,553
+12% +$20.6M
ABBV icon
29
AbbVie
ABBV
$465B
$179M 0.63%
1,198,534
+298,125
+33% +$43.8M
PANW icon
30
Palo Alto Networks
PANW
$256B
$172M 0.61%
1,471,504
+36,630
+3% +$4.33M
DE icon
31
Deere & Co
DE
$165B
$166M 0.58%
440,354
-2,168
-0.5% -$894K
ZTS icon
32
Zoetis
ZTS
$32.7B
$164M 0.58%
940,694
+64,762
+7% +$11.8M
MRK icon
33
Merck
MRK
$322B
$159M 0.56%
1,546,004
-172,109
-10% -$18.6M
AMGN icon
34
Amgen
AMGN
$209B
$158M 0.56%
588,962
+73,400
+14% +$18.3M
ADP icon
35
Automatic Data Processing
ADP
$109B
$158M 0.56%
656,393
+34,087
+5% +$8.31M
TJX icon
36
TJX Companies
TJX
$179B
$150M 0.53%
1,686,247
-99,656
-6% -$8.77M
ABT icon
37
Abbott
ABT
$188B
$148M 0.52%
1,524,171
+58,985
+4% +$6.2M
JNJ icon
38
Johnson & Johnson
JNJ
$640B
$145M 0.51%
928,282
-64,321
-6% -$10.6M
BMY icon
39
Bristol-Myers Squibb
BMY
$129B
$142M 0.5%
2,450,273
+279,415
+13% +$17.1M
TXN icon
40
Texas Instruments
TXN
$248B
$141M 0.5%
889,278
+120,969
+16% +$20.6M
BSX icon
41
Boston Scientific
BSX
$68.4B
$138M 0.49%
2,618,266
-147,856
-5% -$7.75M
ADSK icon
42
Autodesk
ADSK
$51.8B
$137M 0.48%
662,054
+108,772
+20% +$22.9M
BDX icon
43
Becton Dickinson
BDX
$46.4B
$135M 0.47%
522,431
-24,303
-4% -$6.56M
CAT icon
44
Caterpillar
CAT
$361B
$133M 0.47%
488,667
-29,189
-6% -$7.92M
GILD icon
45
Gilead Sciences
GILD
$165B
$131M 0.46%
1,746,761
+85,819
+5% +$6.6M
MA icon
46
Mastercard
MA
$498B
$127M 0.45%
320,236
-150,349
-32% -$60.4M
BKNG icon
47
Booking.com
BKNG
$156B
$126M 0.44%
1,019,650
-105,800
-9% -$12.8M
LIN icon
48
Linde
LIN
$236B
$126M 0.44%
337,765
+66,829
+25% +$25.4M
AMD icon
49
Advanced Micro Devices
AMD
$700B
$125M 0.44%
1,213,758
-82,938
-6% -$9M
INTU icon
50
Intuit
INTU
$91.1B
$117M 0.41%
228,578
+23,200
+11% +$11.7M

Similar funds

Axa's Q3 2023 Portfolio in Review

As of Q3 2023, Axa held 1,182 positions worth $28.5B, down 5.5% from $30.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Axa's Q3 2023 filing shows 104 new, 354 increased, 497 reduced and 123 closed positions. Its largest new stake was Invesco: 1,126,202 shares worth $16.4M. The largest sale was Silicon Laboratories, an estimated $84.9M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q3 2023 buy was Invesco: 1,126,202 shares worth $16.4M.
  • Axa added most to Applied Materials in Q3 2023, an estimated $94.3M increase.
  • Axa's biggest Q3 2023 reduction was Silicon Laboratories, cutting an estimated $84.9M.
  • Axa fully exited Life Storage, Inc. in Q3 2023, selling an estimated $19.3M.
  • Axa's ten largest holdings make up 23% of its $28.5B portfolio in Q3 2023.
  • Axa opened 104 new positions and closed 123 in Q3 2023.
  • Axa's portfolio value fell 5.5% quarter-over-quarter to $28.5B.

Based on Axa's 13F filing for Q3 2023, filed 14 Nov 2023.